French Govt Plans To Boost Access To Innovation & Increase Use Of Generics & Biosimilars
Executive Summary
The French government’s health strategy for 2018-2022 includes a range of measures to increase patient access to new medicines, raise the level of generic and biosimilar prescribing, and cut down on the use of antibiotics.